14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CNTA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for Centessa Pharmaceuticals Limited
(Updated on May 02, 2024)

Sell candidate since Apr 12, 2024 Loss -15.64% PDF

The Centessa Pharmaceuticals Limited stock price gained 0.738% on the last trading day (Thursday, 2nd May 2024), rising from $9.48 to $9.55. During the last trading day the stock fluctuated 4.57% from a day low at $9.19 to a day high of $9.61. The price has been going up and down for this period, and there has been a -9.31% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 67 thousand more shares were traded than the day before. In total, 299 thousand shares were bought and sold for approximately $2.85 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.44% during the next 3 months and, with a 90% probability hold a price between $8.12 and $12.81 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CNTA Signals & Forecast

There are mixed signals in the stock today. The Centessa Pharmaceuticals Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $10.64. On a fall, the stock will find some support from the short-term average at $9.26. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 22, 2024, and so far it has fallen -21.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. The stock had a Golden Star Signal on Wednesday, December 13, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Wednesday, December 13, 2023 in the long-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Centessa Pharmaceuticals Limited stock

Centessa Pharmaceuticals Limited finds support from accumulated volume at $9.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.420 between high and low, or 4.57%. For the last week, the stock has had daily average volatility of 5.35%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CNTA) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Centessa Pharmaceuticals Limited to open at $9.45, and during the day (based on 14 day Average True Range), to move between $8.88 and $10.22, which gives a possible trading interval of +/-$0.670 (+/-7.02%) up or down from last closing price. If Centessa Pharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 14.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $9.60 (0.52%) than the support at $9.46 (0.94%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Centessa Pharmaceuticals Limited will release earnings BMO on Friday, May 10, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.410. We will update the financials statements for Centessa Pharmaceuticals Limited, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.02% in the first trading day after earnings release.

Is Centessa Pharmaceuticals Limited stock A Buy?

Centessa Pharmaceuticals Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.946 Sell Candidate Unchanged

Predicted Opening Price for Centessa Pharmaceuticals Limited of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$9.45 ( 1.05%) $9.55

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CNTA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.87 3.35 %
R2 9.71 1.67 %
R1 9.61 0.633 %
Current price: 9.55
Support S1 9.29 -2.73 %
S2 9.19 -3.77 %
S3 9.03 -5.45 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.40 8.90 %
R2 10.18 6.60 %
R1 9.60 0.524 %
Current price 9.55
Support S1 9.46 -0.94%
S2 9.26 -3.04%
S3 8.15 -14.66%

FAQ

What is the symbol for Centessa Pharmaceuticals Limited Stock and on which exchange is it traded?
The symbol for Centessa Pharmaceuticals Limited is CNTA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Centessa Pharmaceuticals Limited Stock?
Centessa Pharmaceuticals Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Centessa Pharmaceuticals Limited Stock?
Centessa Pharmaceuticals Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Centessa Pharmaceuticals Limited Stock.

What's the current price of Centessa Pharmaceuticals Limited Stock?
As of the end of day on the May 02, 2024, the price of an Centessa Pharmaceuticals Limited (CNTA) share was $9.55.

What is the 52-week high and low for Centessa Pharmaceuticals Limited Stock?
The 52-week high for Centessa Pharmaceuticals Limited Stock is $12.41 and the 52-week low is $3.96.

What is the market capitalization of Centessa Pharmaceuticals Limited Stock?
As of the May 02, 2024, the market capitalization of Centessa Pharmaceuticals Limited is 936.385M.

When is the next earnings date for Centessa Pharmaceuticals Limited?
The upcoming earnings date for Centessa Pharmaceuticals Limited is May 10, 2024.
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT